Monitor the voting results for any unexpected opposition to director elections or auditor ratification, which could indicate shareholder concerns. Otherwise, this is a standard annual meeting with no immediate financial implications.
Price Chart
Executive Summary
Caribou Biosciences is holding its 2026 annual meeting where shareholders will vote on electing three Class II directors, ratifying Deloitte & Touche LLP as auditors, approving an amendment to exculpate officers from certain fiduciary duties, and adjourning the meeting if needed. This is a routine annual shareholder meeting with no material financial impact.
Key Facts
- Election of three Class II directors: Andrew Guggenhime, David Johnson, and Nancy Whiting
- Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026
- Approval of amendment to provide for exculpation of officers from certain breaches of fiduciary duty
- Approval of adjourning the 2026 Annual Meeting if necessary for further solicitation of proxies
Financial Impact
No direct financial impact from these proposals
Risk Factors
- Potential shareholder opposition to officer exculpation amendment
- Unexpected vote against auditor ratification could signal governance concerns
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001619856-26-000023 |
| Document: 0001619856-26-000023-index-headers.html | 0001619856-26-000023 |
| Document: 0001619856-26-000023-index.html | 0001619856-26-000023 |
| Document: 0001619856-26-000023.txt | 0001619856-26-000023 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | 8-K | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−26.20%) |
Jun 11, 2026 16w ago | Press Release | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−26.20%) |
Jun 5, 2026 16w ago | DEFA14A | $1.84 $1.83 | ▼ −0.54% | ▼ −2.17% | $1.23 (−33.42%) |
Apr 24, 2026 22w ago | DEFA14A | $2.13 $2.16 | ▲ +1.41% | ▼ −3.55% | $1.23 (−42.49%) |
Mar 5, 2026 30w ago | 8-K | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.69%) |
Mar 5, 2026 30w ago | Press Release | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.69%) |
Feb 28, 2026 30w ago | Institutional Cluster | $1.84 $1.72 | ▼ −6.52% | ▲ +1.42% | $1.23 (−33.42%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access